- Report
- August 2025
- 150 Pages
Global
From €2959EUR$3,358USD£2,599GBP
€3481EUR$3,950USD£3,057GBP
- Report
- September 2025
- 148 Pages
Global
From €3633EUR$4,123USD£3,191GBP
€4274EUR$4,850USD£3,754GBP
- Report
- May 2025
- 200 Pages
Asia Pacific
From €2194EUR$2,490USD£1,927GBP
- Report
- November 2024
- 130 Pages
Global
From €5243EUR$5,950USD£4,605GBP
- Report
- July 2022
- 298 Pages
Global
From €2313EUR$2,625USD£2,032GBP
€3084EUR$3,500USD£2,709GBP
- Report
- May 2024
- 135 Pages
Global
From €4868EUR$5,524USD£4,276GBP
€5727EUR$6,499USD£5,030GBP
- Report
- July 2023
- 118 Pages
Global
From €3965EUR$4,500USD£3,483GBP
- Report
- August 2022
- 120 Pages
Global
From €3965EUR$4,500USD£3,483GBP
- Report
- August 2022
- 119 Pages
Global
From €3965EUR$4,500USD£3,483GBP
- Report
- March 2025
- 200 Pages
India
From €2194EUR$2,490USD£1,927GBP
- Report
- May 2021
- 50 Pages
China
From €2291EUR$2,600USD£2,012GBP
- Report
- June 2024
- 101 Pages
Global
From €2785EUR$3,160USD£2,446GBP
€3481EUR$3,950USD£3,057GBP
- Report
- June 2024
- 200 Pages
Global
From €5604EUR$6,360USD£4,923GBP
€7006EUR$7,950USD£6,153GBP
- Report
- June 2024
- 200 Pages
Global
From €5604EUR$6,360USD£4,923GBP
€7006EUR$7,950USD£6,153GBP
- Report
- June 2024
- 200 Pages
Global
From €5604EUR$6,360USD£4,923GBP
€7006EUR$7,950USD£6,153GBP
- Report
- June 2024
- 200 Pages
Global
From €5604EUR$6,360USD£4,923GBP
€7006EUR$7,950USD£6,153GBP
- Report
- June 2024
- 200 Pages
Global
From €5604EUR$6,360USD£4,923GBP
€7006EUR$7,950USD£6,153GBP
- Report
- June 2024
- 200 Pages
Global
From €5604EUR$6,360USD£4,923GBP
€7006EUR$7,950USD£6,153GBP
- Report
- June 2024
- 200 Pages
Global
From €5604EUR$6,360USD£4,923GBP
€7006EUR$7,950USD£6,153GBP
- Report
- June 2024
- 200 Pages
Global
From €5604EUR$6,360USD£4,923GBP
€7006EUR$7,950USD£6,153GBP

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs.
Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more